Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

WOK vs TDIC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

WOK Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 5–2 Matrix Metrics)

WOK Overall Winner 6-Pillar Tally: WOK 3 – 2 TDIC (1 Tie) Matrix Metrics: WOK 5 – 2 TDIC

As of Nov 16, 2026, WORK Medical Technology Group LTD Class A (WOK) is the stronger overall head-to-head candidate over Dreamland Limited Class A (TDIC) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas TDIC carries 42.6/100 (HOLD) at $1.44 (N/M Forward P/E, -124.2% operating margin).

  • Composite vs. Pillar Nuance: While TDIC currently prints a higher short-term Unified Composite Score (42.6/100 HOLD vs. WOK 25.6/100 SELL), WOK captures the overall institutional head-to-head verdict (5–2 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-41.7% vs. -124.2% operating margin) and revenue trajectory (+19.1% vs. -27.5% YoY).
  • Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile TDIC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WOK vs TDIC
WOK NASDAQ Head-to-Head Winner
WORK Medical Technology Group LTD Class A Ordinary Shares
Surgical & Medical Instruments & Apparatus
$1.23
+2.5% 1D
Market Cap $5.4M
TTM Revenue $11M
Forward P/E N/M
Beta / 30D Vol 38.49β · 153% Vol
Unified Composite Score
25.6 / 100 SELL
Tech 5.0 Fund 39.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.1 · SMA20: $1.13 · SMA50: $1.47
TDIC NASDAQ
Dreamland Limited Class A Ordinary Shares
Services-Management Services
$1.44
+0.0% 1D
Market Cap $5.3M
TTM Revenue $51M
Forward P/E N/M
Beta / 30D Vol 28.22β · 76% Vol
Unified Composite Score
42.6 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -17.2%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.61 · SMA50: $1.89

6-Pillar Scorecard Institutional Category Breakdown (WOK 3 – 2 TDIC)

Columns: Metric · WOK · TDIC
1. Valuation Multiples TDIC
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.5x 0.1x
2. Growth & Scale TDIC
Revenue Growth (YoY) +19.1% -27.5%
Earnings Growth (YoY) -95.0% -35.2%
TTM Revenue (USD) $11M $51M
Market Cap $5.4M $5.3M
3. Profitability & Quality WOK
Gross Margin 17.0% 0.9%
Operating Margin -41.7% -124.2%
Net Profit Margin -41.9% -146.1%
Return on Equity (ROE) -19.2% -1012.1%
4. Balance Sheet & Cash Flow WOK
Cash Generation (TTM) -$3.4M EBITDA -$63M EBITDA
Cash Flow Margin -31.4% EBITDA Mgn -124.0% EBITDA Mgn
Net Cash / Leverage $1855.16 Book/Sh · -19.2% ROE $2.46 Book/Sh · -1012.1% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat WOK
OpEx & R&D Intensity 58.7% of Rev ($6.3M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Advertising Agencies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WOK (5) vs TDIC (2)
Institutional Metric WOK TDIC Criterion Row Edge
Market Capitalization
Scale
$5.4M $5.3M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+19.1% -27.5% Higher Growth WOK
Operating Margin (TTM)
Profitability
-41.7% -124.2% Higher Margin WOK
Net Profit Margin
Profitability
-41.9% -146.1% Higher Margin WOK
Return on Equity (ROE)
Capital Efficiency
-19.2% -1012.1% Higher ROE WOK
52-Week Range Position
Momentum
16% ($0–$7) 4% ($0–$30) Stronger Trend WOK
Beta / 30D Volatility
Risk Regime
38.49β · 153% Vol 28.22β · 76% Vol Lower Realized Risk TDIC
Unified Institutional Score
Composite Signal
25.6 / 100 (SELL) 42.6 / 100 (HOLD) Higher Composite TDIC
Trailing 12M Revenue (USD)
Operating Scale
$11M $51M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.0% 0.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.5x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$3.4M EBITDA ($1855.16 Book/Sh · -19.2% ROE) -$63M EBITDA ($2.46 Book/Sh · -1012.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon WOK +38.61 pp
WOK: +12.84% · TDIC: -25.77%
3M Horizon WOK +2.77 pp
WOK: -44.09% · TDIC: -46.86%
6M Horizon WOK +119.74 pp
WOK: +223.68% · TDIC: +103.94%
1Y Horizon TDIC +278.43 pp
WOK: -72.05% · TDIC: +206.38%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WOK vs TDIC. Trailing 12-month operating profitability (WOK -41.7% vs TDIC -124.2%) and valuation multiples (WOK N/M vs TDIC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

WOK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$11M
Gross Margin17.0%
Op. Margin-41.7%
ROE / Fwd P/E-19.2% · N/M
TDIC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$51M
Gross Margin0.9%
Op. Margin-124.2%
ROE / Fwd P/E-1012.1% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WOK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WOK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TDIC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TDIC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WOK Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $5.4M market capitalization and -41.7% operating margin.
OpEx & R&D Reinvestment 58.7% of Rev ($6.3M)
90D Engineering Disclosures 0 Published
TDIC Moat Profile Cyclical / Execution-Driven Positioning
Advertising Agencies Operator
Competes within the Advertising Agencies value chain with $5.3M market capitalization and -124.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ WOK vs TDIC Key Questions & Quantitative Answers

As of Nov 16, 2026, WORK Medical Technology Group LTD Class A (WOK) is the stronger overall head-to-head candidate over Dreamland Limited Class A (TDIC) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas TDIC carries 42.6/100 (HOLD) at $1.44 (N/M Forward P/E, -124.2% operating margin). Composite vs. Pillar Nuance: While TDIC currently prints a higher short-term Unified Composite Score (42.6/100 HOLD vs. WOK 25.6/100 SELL), WOK captures the overall institutional head-to-head verdict (5–2 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-41.7% vs. -124.2% operating margin) and revenue trajectory (+19.1% vs. -27.5% YoY). Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile TDIC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TDIC leads the Growth & Scale pillar: WOK posts +19.1% YoY revenue growth and -95.0% YoY earnings growth on $11M TTM revenue (17.0% gross margin, -41.7% operating margin), compared with TDIC at -27.5% YoY revenue growth and -35.2% YoY earnings growth on $51M TTM revenue (0.9% gross margin, -124.2% operating margin). On trailing 12-month operating scale, WOK generates $11M in USD-normalized revenue versus $51M for TDIC. In operating R&D and SG&A reinvestment, WOK deploys 58.7% of Rev ($6.3M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TDIC.

TDIC screens cheaper on headline valuation multiples. WOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-31.4% EBITDA margin), whereas TDIC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-124.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WOK (-19.2% ROE) versus TDIC (-1012.1% ROE) capital efficiency.

In options market volatility and institutional positioning, WOK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (38.49β · 153% Vol realized risk). By comparison, TDIC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (28.22β · 76% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

WORK Medical Technology Group LTD Class A Ordinary Shares (WOK) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.